Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC24H24F2N6O3 |
InChIKeyLMRCQVHTZUUHFN-UHFFFAOYSA-N |
CAS Registry1445830-39-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Discovery | Germany | - |





